ARCHIVES

FDA Approves Xeloda For Colon Cancer; Phase III Data Not Reviewed By ODAC.

This article is from The Cancer Letter archive.

Vol. 27 No. 18 | May 4, 2001

Download PDF Visit The Full Archive

Related Articles

Kennedy Tells ASCO Members To Lobby For High Tar, Nicotine Tax

April 7, 1978

Freireich Blasts Prevention Advocates, Defends Treatment

September 15, 1978

Sam Broder Receives Arthur Flemming Award

June 1, 1984

NCI Grant Funding Up $74 Million; Centers, Groups also Receive Funding Boost

March 8, 1996

In Brief: UICC Publishes International directory Of Cancer Centers; HSAs Still Worry NCI

January 7, 1977

Minimally Invasive Surgery Results In Lower Mortality Rate For Esophageal Removal

April 25, 2003